ArticleAmerican journal of ophthalmology2025

Targeting the Tie-2 Receptor With Faricimab in Central Serous Chorioretinopathy: A Case Series Motivated by a Genetic Finding.

Joel T Rämö et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.